Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn

Pediatrics

Volumn 98, Issue 4 PART 1, 1996, Pages 706-713

  Goldman, Allan P ^a   Tasker, Robert C ^a   Haworth, Sheila G ^a   Sigston, Paul E ^a   Macrae, Duncan J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Inhaled nitric oxide; Oxygenation index; Persistent pulmonary hypertension of the newborn

Indexed keywords

NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; DOSE RESPONSE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG HYPOPLASIA; MALE; MECONIUM ASPIRATION; METHEMOGLOBINEMIA; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BIOPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFANT, NEWBORN; LUNG; MALE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY SYSTEM AGENTS; TREATMENT OUTCOME;

EID: 0029819053     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Roberts JD, Shaul PW. Advances in the treatment of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am. 1993;40,5: 983-1004
2. Hislop AA, Haworth SG. Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. Am Rev Respir Dis. 1989;140:1717-1726
3. Haworth SG. Pulmonary vascular remodeling in neonatal pulmonary hypertension-state of the art. Chest. 1988;93(suppl):133S-138S
4. Reid LM. Constrictive and restrictive pulmonary hypertension in the newborn and infant. Am J Cardiovasc Pathol. 1987;1:287-299
5. Reid LM. Structure and function in pulmonary hypertension. New perceptions. Chest. 1986;89:279-288
6. Cater G, Thibeault DW, Beatty ECJ, et al. Misalingnment of lung vessels and alveolar capillary dysplasia: a cause of persistent pulmonary hypertension. J Pediatr. 1989;114:293-300
7. Bartlett RH, Roloff DW, Cornell RG, et al. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985;76:479-487
8. O'Rourke PP, Crone RK, Vacant! JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989;84:957-963
9. Short BL, Miller MK, Anderson KD. Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol. 1987;14:737-748
10. Stork E. Extracorporeal membrane oxygenation in the newborn and beyond. Clin Perinatol. 1988;15:815-829
11. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurty IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990;259:H1921-H1927
12. Cornfield DN, Chatfield BA, McQueston JA, McMurtry IF, Abman SH. Effects of birth-related stimuli on L-arginine dependent pulmonary vasodilatation in the ovine fetus. Am J Physiol. 1992;262:H1474-H1481
13. Davidson D, Eldermedash A. Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resistance in the isolated newborn guinea pig lung. Pediatr Res. 1991;29:538-542
14. Tiktinsky MN, Morin FC. Increasing oxygen tension dilates fetal pulmonary circulation by endothelium-derived relaxing factor. Am J Physiol. 1993;265:H376-H380
15. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am J Physiol. 1992;262: H1365-H1371
16. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819-820
17. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340: 818-819
18. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993;123: 103-108
19. Finer NN, Etches PC, Kamstra B, Tierney AJ, Pellowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr. 1994;124:302-308
20. Miller OI, Celemajer DS, Deanfield JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child. 1994;70: F47-49
21. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med. 1967;276:357-358
22. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993;328:399-405
23. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr. 1994;124:881-888
24. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3′:5′monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther. 1981;219:181-186
25. Young JD, Dyar O, Xiong L, Howell S. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intensive Care Med. 1994;20:581-584